Harvard Apparatus Regenerative Technology Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 8.95 million compared to USD 6.07 million a year ago. Basic loss per share from continuing operations was USD 0.67 compared to USD 0.55 a year ago.
Harvard Apparatus Regenerative Technology Inc.
Equities
HRGN
US09074M2026
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +3.11% | -5.69% | -53.51% |
1st Jan change | Capi. | |
---|---|---|
-53.51% | 33.21M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- HRGN Stock
- News Harvard Apparatus Regenerative Technology Inc.
- Harvard Apparatus Regenerative Technology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023